Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
15 Mar 2022 |
On significant placements in financial instruments |
Bestinver announces details of an accelerated book building process of approximately 5% of the share capital of Laboratorios Farmacéuticos Rovi, S.A.
|
Download |
|
14 Mar 2022 |
On significant placements in financial instruments |
Bestinver announces the beginning of an accelerated book building process approximately 5% of the share capital of Laboratorios Farmacéuticos Rovi, S.A.
|
Download |
|
23 Feb 2022 |
On business and financial situation |
The Company releases the press release related to the full year 2021 financial results
|
Download |
|
23 Feb 2022 |
On business and financial situation |
The Company releases the full year 2021 financial results presentation
|
Download |
|
23 Feb 2022 |
About corporate governance |
The Company informs about the agreements adopted by the Board of Directors
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
28 Jul 2023 |
On business and financial situation |
ROVI informs on the evaluation process to obtain marketing authorisation for Risvan®
|
Download |
|
05 Jul 2023 |
Liquidity and counterparty agreements |
Liquidity contract: transactions conducted in the second quarter of 2023
|
Download |
|
26 Jun 2023 |
Other relevant information |
The Company informs about the dividends payment
|
Download |
|
14 Jun 2023 |
Announcement of general shareholders’ meeting |
ROVI releases the information related to its General Shareholders Meeting.
|
Download |
|
31 May 2023 |
Other relevant information |
ROVI informs about the news items that have appeared in several media today regarding ROVI’s receipt of government grants
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
06 Apr 2017 |
Contratos de liquidez y contrapartida |
Liquidity contract: transactions conducted in the first quarter of 2017
|
Download |
|
13 Mar 2017 |
Otros sobre negocio y situación financiera |
The Company releases the presentation related to its biosimilar of Enoxaparin
|
Download |
|
07 Mar 2017 |
Otros sobre negocio y situación financiera |
ROVI informs that the Decentralised procedure used for the registration of its biosimilar of enoxaparin has been completed with positive outcome
|
Download |
|
16 Feb 2017 |
Otros sobre Gobierno Corporativo |
The Company informs about the agreements adopted by the Board of Directors
|
Download |
|
16 Feb 2017 |
Informe anual de remuneraciones de los consejeros |
ROVI releases the 2016 annual report regarding remuneration of the members of the Board of Directors
|
Download |
Pages
